Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_assertion type Assertion NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_head.
- NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_assertion description "[Conversely, treatment of prostate cancer cells with an inhibitor of miR-125b (anti-miR-125b) resulted in increased expression of p14(ARF), decreased level of Mdm2, and induction of apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_provenance.
- NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_assertion evidence source_evidence_literature NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_provenance.
- NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_assertion SIO_000772 23585871 NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_provenance.
- NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_assertion wasDerivedFrom befree-20150227 NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_provenance.
- NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_assertion wasGeneratedBy ECO_0000203 NP551066.RAsvMXqGVI2rsZkPfL5Lf59D2QAeS2SwmwcBTD3WJMwpg130_provenance.